These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10908682)

  • 1. Neuroprotective potential of a viral vector system induced by a neurological insult.
    Ozawa CR; Ho JJ; Tsai DJ; Ho DY; Sapolsky RM
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9270-5. PubMed ID: 10908682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective herpes simplex virus vectors expressing the rat brain glucose transporter protect cultured neurons from necrotic insults.
    Ho DY; Saydam TC; Fink SL; Lawrence MS; Sapolsky RM
    J Neurochem; 1995 Aug; 65(2):842-50. PubMed ID: 7616244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system.
    Ho DY; McLaughlin JR; Sapolsky RM
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):200-9. PubMed ID: 8883953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A herpes simplex virus vector overexpressing the glucose transporter gene protects the rat dentate gyrus from an antimetabolite toxin.
    Dash R; Lawrence M; Ho D; Sapolsky R
    Exp Neurol; 1996 Jan; 137(1):43-8. PubMed ID: 8566211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 27 delivered via a herpes simplex virus vector can protect neurons of the hippocampus against kainic-acid-induced cell loss.
    Kalwy SA; Akbar MT; Coffin RS; de Belleroche J; Latchman DS
    Brain Res Mol Brain Res; 2003 Mar; 111(1-2):91-103. PubMed ID: 12654509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations in the neuroprotective potential of gene therapy with Bcl-2.
    Phillips RG; Lawrence MS; Ho DY; Sapolsky RM
    Brain Res; 2000 Mar; 859(2):202-6. PubMed ID: 10719065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss.
    Lawrence MS; Ho DY; Dash R; Sapolsky RM
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7247-51. PubMed ID: 7638175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adenoviral vector expressing the glucose transporter protects cultured striatal neurons from 3-nitropropionic acid.
    Fink SL; Ho DY; McLaughlin J; Sapolsky RM
    Brain Res; 2000 Mar; 859(1):21-5. PubMed ID: 10720611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective herpes simplex virus vectors expressing the rat brain stress-inducible heat shock protein 72 protect cultured neurons from severe heat shock.
    Fink SL; Chang LK; Ho DY; Sapolsky RM
    J Neurochem; 1997 Mar; 68(3):961-9. PubMed ID: 9048741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection with herpes simplex vectors expressing virally derived anti-apoptotic agents.
    Roy M; Hom J; Sapolsky RM
    Brain Res; 2001 May; 901(1-2):12-22. PubMed ID: 11368945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene.
    Ho DY; Mocarski ES; Sapolsky RM
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3655-9. PubMed ID: 8386379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSV-mediated delivery of virally derived anti-apoptotic genes protects the rat hippocampus from damage following excitotoxicity, but not metabolic disruption.
    Roy M; Hom JJ; Sapolsky RM
    Gene Ther; 2002 Feb; 9(3):214-9. PubMed ID: 11859425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer with herpes simplex vectors.
    Lachmann RH; Efstathiou S
    Curr Opin Mol Ther; 1999 Oct; 1(5):622-32. PubMed ID: 11249669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene delivery using herpes simplex virus vectors.
    Burton EA; Fink DJ; Glorioso JC
    DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector.
    Huard J; Akkaraju G; Watkins SC; Pike-Cavalcoli M; Glorioso JC
    Hum Gene Ther; 1997 Mar; 8(4):439-52. PubMed ID: 9054519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke.
    Lawrence MS; McLaughlin JR; Sun GH; Ho DY; McIntosh L; Kunis DM; Sapolsky RM; Steinberg GK
    J Cereb Blood Flow Metab; 1997 Jul; 17(7):740-4. PubMed ID: 9270490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo.
    Lawrence MS; Ho DY; Sun GH; Steinberg GK; Sapolsky RM
    J Neurosci; 1996 Jan; 16(2):486-96. PubMed ID: 8551333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective viral vectors as agents for gene transfer in the nervous system.
    Kaplitt MG; Makimura H
    J Neurosci Methods; 1997 Jan; 71(1):125-32. PubMed ID: 9125381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy.
    Yenari MA; Fink SL; Sun GH; Chang LK; Patel MK; Kunis DM; Onley D; Ho DY; Sapolsky RM; Steinberg GK
    Ann Neurol; 1998 Oct; 44(4):584-91. PubMed ID: 9778256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.